{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:43:05Z","timestamp":1780652585598,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dental Clinics of North America"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.cden.2004.08.003","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:11Z","timestamp":1113835991000},"page":"67-76","source":"Crossref","is-referenced-by-count":43,"title":["Erythema multiforme: a review and contrast from Stevens-Johnson syndrome\/toxic epidermal necrolysis"],"prefix":"10.1016","volume":"49","author":[{"given":"P. Michele","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cden.2004.08.003_bib1","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"636","article-title":"Erythema multiforme","author":"Fritsch","year":"1999"},{"key":"10.1016\/j.cden.2004.08.003_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1085-5629(96)80036-8","article-title":"Epidemiology of drug-induced severe skin reactions","volume":"15","author":"Mockenhaupt","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.cden.2004.08.003_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiforme: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib4","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","article-title":"Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus","volume":"26","author":"Saiag","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","article-title":"Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib8","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme major, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0190-9622(84)80090-0","article-title":"Erythema multiforme: clinical, histopathologic, and immunologic study","volume":"10","author":"Howland","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0560.1994.tb00281.x","article-title":"Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme","volume":"21","author":"Brice","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cden.2004.08.003_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib14","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Steven-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cden.2004.08.003_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000247299","article-title":"Evolving pattern of drug-induced toxic epidermal necrolysis","volume":"186","author":"Correia","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.cden.2004.08.003_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/adc.83.4.347","article-title":"Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome","volume":"83","author":"Leaute-Labreze","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cden.2004.08.003_bib17","first-page":"1","article-title":"Herpes simplex virus (HSV) associated erythema multiforme (HAEM): a viral disease with an autoimmune component","volume":"9","author":"Aurelian","year":"2003","journal-title":"Dematol Online J"},{"key":"10.1016\/j.cden.2004.08.003_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-\u03b3 is expressed in HAEM lesions and tumor necrosis factor-\u03b1 in drug-induced erythema multiforme lesions","volume":"113","author":"Kokuba","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000372-199704000-00005","article-title":"Erythema multiforme and toxic epidermal necrolysis: a comparative study","volume":"19","author":"Paquet","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.cden.2004.08.003_bib20","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1001\/jama.249.20.2810","article-title":"Recurrent oral erythema multiforme","volume":"249","author":"Bean","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.cden.2004.08.003_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archderm.1993.01680270059007","article-title":"Impaired antigen presentation in toxic epidermal necrolysis","volume":"129","author":"Bagot","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib22","series-title":"Fitzpatrick's dermatology in general medicine","first-page":"644","article-title":"Stevens-Johnson syndrome\u2013toxic epidermal necrolysis","author":"Fritsch","year":"1999"},{"key":"10.1016\/j.cden.2004.08.003_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.08.003_bib24","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case controlled study","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cden.2004.08.003_bib25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cden.2004.08.003_bib26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809040-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to a regional burn unit","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cden.2004.08.003_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00004630-199711000-00009","article-title":"Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage","volume":"18","author":"Engelhardt","year":"1997","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.cden.2004.08.003_bib28","first-page":"721","article-title":"Toxic epidermal necrolysis","volume":"120","author":"Westly","year":"1984","journal-title":"Granulocytic leucopenia as a prognostic indicator"},{"key":"10.1016\/j.cden.2004.08.003_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"}],"container-title":["Dental Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853204001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853204001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T07:25:04Z","timestamp":1548573904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011853204001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0011853204001016"],"URL":"https:\/\/doi.org\/10.1016\/j.cden.2004.08.003","relation":{},"ISSN":["0011-8532"],"issn-type":[{"value":"0011-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}